Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

My guest this week believes that our problems today can be traced back to the sexual revolution. She argues that it reset ...

What are the most exciting advances in medicine on the horizon, the ones that could prevent or treat our biggest killers like ...

New 2026 research from Finland finds HIF-PHI anemia medications may slow cancer cell growth and block tumor blood vessels ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...

Michael Kaplan is an award-winning reporter and producer for the CBS News Investigative Unit. He specializes in securing scoops and crafting long-form television investigations. His work has appeared ...

So a netizen asked the people of the internet to share their wisdom on what things that appear to be scams actually work ...